RNA-targeted therapies — ones that zero in on molecules acting as messengers for genetic information in cells — are safe…
Andrea Lobo
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo
Undergoing a liver transplant and/or receiving disease-modifying treatments significantly improves survival in people with hereditary transthyretin amyloidosis (hATTR), a group…
A specialized MRI technique known as the variable echo time (vTE) sequence may help identify structural changes in nerves linked…
A higher proportion of fat in the tissue that surrounds peripheral nerves, as assessed with a noninvasive MRI scan, may…
Sudoscan, a test used to indirectly assess small nerve fiber damage through sweat gland function, may be a marker of…
Throughout 2024, Amyloidosis News Today informed our readers about the latest developments in treatment and clinical trials for…
Gly103Arg, a mutation in the TTR gene that has been exclusively reported in Chinese people, is associated with a…
Combination therapy for hereditary transthyretin amyloidosis (hATTR), a group of conditions including familial amyloid polyneuropathy (FAP), appears to be…
A man carrying p.Val142Ile, a TTR gene mutation often linked to a condition related to familial amyloid polyneuropathy (FAP)…
A new mutation in the TTR gene was identified as the cause of late-onset familial amyloid polyneuropathy (FAP) in…